observed in cardiac myocytes (2) . The hyperglycemia in diabetes or high-glucose ambience in cell culture systems are known to be associated with high levels of reactive oxygen species (ROS) (5) . Thus, relevance of ROS in the biology of TRB3 was investigated. Both hydrogen peroxide and ROS synthesized via the xanthine oxidase reaction augmented the TRB3 expression. Similarly, palmitate, a dominant circulating free fatty acid (FFA) in diabetes and the metabolic syndrome, generated in response to ROS stress, also augmented the TRB3 expression. This finding is novel and would be of great interest, and it reconciles with the observations of Montminy's group (14) that TRB3 stimulates lipolysis by promoting the degradation of acetyl-coenzyme A carboxylase, the rate-limiting enzyme of fatty acid synthesis. Along these lines, Liew et al. (8) also reported recently that palmitate upregulates TRB3 expression in human and mouse islets. These perplexing observations led Cunard's group to suggest that TRB3 upregulation may be involved in a negative feedback loop that augments the oxidation of FFAs. This hypothesis is appealing but it would necessitate further investigations to assess its applicability in classic insulin-sensitive tissues.
Nevertheless, the authors delineated certain other mechanisms by which TRB3 is upregulated and how the increased expression could dampen the renal injury in diabetes. They devoted their efforts to study the stress in the Endoplasmic Reticulum (ER); the latter folds and modifies cellular proteins. When cells are stressed by ROS, nutrient deprivation, and hypoxia, unfolded proteins accumulate in the ER and activate the Unfolded Protein Response (UPR). The UPR is a signaling pathway that functions to restore normal ER activity and it is characterized by the expression of a classic group of proteins including transcription factors, such as ATF4, C/EBP homologous protein (CHOP), BiP/GRP78, and XBP; and earlier work by Ord and Ord (12) suggested that TRB3 interacts with ATF4. Thus, the TRB3 is now considered as an ER stressregulated protein. In the current work, the link between ER stress and TRB3 is strengthened as CHOP was shown to regulate TRB3 expression in podocytes, which is augmented by ROS and FFA. The CHOP has been considered proapoptotic, and further studies are needed to evaluate whether CHOP and TRB3 induce cellular apoptosis and effacement of glomerular podocytes.
The punch line of the studies by Cunard's group is exploration of the mechanism(s) by which TRB3 conceivably can serve as a protective agent against the inflammatory renal injury induced largely by monocyte chemoattractant protein-1 (MCP-1) in diabetic nephropathy (11) . TheTRB3 has been shown to alter signaling pathways including those involving AKT and mitogen-activated protein kinases (MAPK) (6) , and it also acts as a transcriptional inhibitor of NF-B (22) . The NF-B modulates the activity of MCP-1, the latter cytokine has emerged as an important mediator of inflammation in many kidney diseases, including in diabetic nephropathy. The dem-onstration that TRB3 specifically inhibits MCP-1 expression in podocytes, most likely by modulating the signaling cascade of AKT-MAPK-NF-B, highlights the value of TRB3 as a potential therapeutic agent for dampening the hyperglycemic injury in diabetic nephropathy. As to whether TRB3 inhibits other inflammatory cytokines in different cell types of the kidney and whether it promotes or reduces cellular survival would be a matter of future investigations.
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